Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 30, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Dedifferentiated chondrosarcoma revisited.

Andreas F Mavrogenis1, Pietro Ruggieri, Mario Mercuri

  • 1Instituto Ortopedico Rizzoli, Bologna, Italy.

Journal of Surgical Orthopaedic Advances
|August 16, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioethics in the era of digital surgery: artificial intelligence, robotics, telesurgery and the surgical black box: who owns the mistakes? Who owns my health data?

International orthopaedics·2026
Same author

A decade of global orthopaedic research in SICOT-J (2015-2025): a scientometric analysis of publication trends, collaboration, and citation impact.

SICOT-J·2026
Same author

The innovation paradox in orthopaedics, high creativity, low protection: lessons and strategic perspectives for surgeons.

International orthopaedics·2026
Same author

Reflections on SICOT-J Volume 11 (2025).

SICOT-J·2026
Same author

Open Reduction and Internal Fixation Versus Suprapatellar Nailing and Condylar Bolts for the Management of Complex Bicondylar Tibial Plateau Fractures: A Clinical Study.

Cureus·2026
Same author

The orthopaedic eye is blind, fluoroscopic vision is simply a brain interpretation, and the robot does not see: Education of the orthopaedic vision in the era of fluoroscopic and robotic illusions.

International orthopaedics·2026
Same journal

Intramedullary Clavicle Fixation Through a Posterolateral Portal: Description of a Novel Minimally Invasive Technique.

Journal of surgical orthopaedic advances·2026
Same journal

Incidence of Nonindicated and Inadequate Ankle Stress Views.

Journal of surgical orthopaedic advances·2026
Same journal

Glenohumeral Pathology Seen at the Time of Diagnostic Arthroscopy After Normal Magnetic Resonance Imaging.

Journal of surgical orthopaedic advances·2026
Same journal

Multivariate Analysis of Social Media Content by United States Orthopaedic Residency Program Directors.

Journal of surgical orthopaedic advances·2026
Same journal

Distal Radius Malunion Correction Without Bone Graft: A Systematic Review.

Journal of surgical orthopaedic advances·2026
Same journal

Sex Differences in the Relationship Between Hand and Leg Dominance and Knee Osteoarthritis Laterality.

Journal of surgical orthopaedic advances·2026
See all related articles

Dedifferentiated chondrosarcoma is a rare, aggressive bone tumor. Treatment involves surgery, radiation, and chemotherapy, but survival remains poor due to frequent metastases.

Area of Science:

  • Orthopedic Oncology
  • Skeletal Tumors
  • Cancer Biology

Background:

  • Dedifferentiated chondrosarcoma is a rare and highly malignant primary bone tumor.
  • It presents with two distinct histopathologic components: a cartilaginous lesion and a high-grade noncartilaginous component.
  • This aggressive nature leads to poor patient survival, often due to metastatic disease.

Purpose of the Study:

  • To review current molecular, biologic, therapeutic, and clinical findings related to dedifferentiated chondrosarcoma.
  • To consolidate recent advancements in understanding and managing this rare bone malignancy.
  • To highlight challenges and outcomes in the treatment of dedifferentiated chondrosarcoma.

Main Methods:

  • Literature review of recent studies on dedifferentiated chondrosarcoma.

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

Related Experiment Videos

Last Updated: May 30, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

  • Analysis of molecular, biologic, therapeutic, and clinical data.
  • Synthesis of findings regarding treatment strategies and patient outcomes.

    • Main Results:

    • Wide or radical surgical resection is the primary mandatory treatment.
    • High-dose radiation therapy is reserved for specific situations like inaccessible tumor sites or palliation.
    • Chemotherapy is considered for chemosensitive dedifferentiated components in patients with good general condition.

    Conclusions:

    • Despite aggressive multimodal treatment, dedifferentiated chondrosarcoma frequently metastasizes.
    • Metastatic progression significantly contributes to the poor survival rates observed in patients.
    • Further research into novel therapeutic strategies is crucial for improving outcomes.